C12Y 302/01049
Alpha-n-acetylgalactosaminidase
Official title: Alpha-N-acetylgalactosaminidase (3.2.1.49)
C12Y302/01049 (Alpha-n-acetylgalactosaminidase) appears on 30 US grants and 31 published applications in this corpus.
Search patents in C12Y- Granted patents
- 30
- Published applications
- 31
- Assignees
- 21
- Inventors
- 58
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 1 |
| 2003 | 0 | 2 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 1 | 1 |
| 2011 | 2 | 2 |
| 2012 | 1 | 1 |
| 2013 | 0 | 2 |
| 2014 | 2 | 2 |
| 2015 | 2 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 2 |
| 2020 | 0 | 1 |
| 2021 | 2 | 4 |
| 2022 | 0 | 1 |
| 2023 | 1 | 2 |
| 2024 | 2 | 3 |
| 2025 | 0 | 2 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Senescence inhibitor21 Apr 2026US 12,605,421 B2Saisei Pharma Co., Ltd.
- Methods and compositions for the treatment of steatosis-associated disorders24 Dec 2024US 12,171,731 B2Duke University
- Methods and compositions for the treatment of cytoplasmic glycogen storage disorders16 Jul 2024US 12,036,190 B2Duke University
- Methods and compositions for the treatment of steatosis-associated disorders4 Jul 2023US 11,690,812 B2Duke University
- Human alpha-N-acetylgalactosaminidase polypeptide22 Jun 2021US 11,040,114 B2Oxyrane UK Limited
- Senescence inhibitor3 Jul 2025US 2025/0213642 A1Saisei Pharma Co., Ltd.
- Enzymatic compositions for carbohydrate antigen cleavage, methods, uses, apparatuses and systems associated therewith9 Jan 2025US 2025/0011749 A1The University of British Columbia
- Methods and Compositions for the Treatment of Cytoplasmic Glycogen Storage Disorders5 Dec 2024US 2024/0398729 A1Duke University
- Enzymatic compositions for carbohydrate antigen cleavage on donor organs, methods and uses associated therewith5 Sep 2024US 2024/0294895 A1The University of British Columbia
- Macrophage activator11 Jan 2024US 2024/0009268 A1Saisei Pharma Co., Ltd.
Most cited
By later US patents
- Production of lysosomal enzymes in plant-based expression systems117US 5,929,304 ACroptech Development Corporation · 1999
- Cloning and expression of biologically active .alpha.-galactosidase A as a fusion protein85US 5,580,757 AMount Sinai School of Medicine of the City University of New York · 1996
- Cloning and expression of biologically active .alpha.-galactosidase A48US 5,401,650 AMount Sinai School of Medicine of the City University of New York · 1995
- Cloning and expression of biologically active .alpha.-n-acetylgalactosaminidase34US 5,382,524 AMount Sinai School of Medicine of the City University of New York · 1995
- Cloning and expression of biologically active .alpha.-N-acetylgalactosaminidase30US 5,491,075 AMount Sinai School of Medicine of the City University of New York · 1996